Evidence map›Paper›PMID 21697501›Full record

Trial reportThe journals of gerontology. Series A, Biological sciences and medical sciences2011

Clinical meaningfulness of the changes in muscle performance and physical function associated with testosterone administration in older men with mobility limitation.

Thomas G Travison, Shehzad Basaria, Thomas W Storer, Alan M Jette, Renee Miciek, Wildon R Farwell, Karen Choong, Kishore Lakshman, Norman A Mazer, Andrea D Coviello and 17 more

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in The journals of gerontology. Series A, Biological sciences and medical sciences, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 76 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
76citing papers in PubMed, 3 pooled it
8.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

76 citing papers in PubMed, 3 syntheses or guidelines pooled it, 157 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Effects of mineralocorticoid receptor antagonists on sex hormones and body composition in patients with primary aldosteronism.Hypertension research : official journal of the Japanese Society of Hypertension · 2022
    Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Effects of Testosterone Treatment in Older Men.The New England journal of medicine · 2016
    Trial
  14. Trial
  15. Trial
  16. Trial
  17. Trial
  18. Trial
  19. Trial
  20. Risk factors associated with cardiovascular events during testosterone administration in older men with mobility limitation.The journals of gerontology. Series A, Biological sciences and medical sciences · 2013
    Trial

16 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors at 4 institutions in 1 country.

Thomas G TravisonSection of Endocrinology, Diabetes, and Nutrition, Boston University School of Medicine and Boston Medical Center, 670 Albany Street, Boston, MA 02118, USA.
Shehzad Basaria
Thomas W Storer
Alan M Jette
Renee Miciek
Wildon R Farwell
Karen Choong
Kishore Lakshman
Norman A Mazer
Andrea D Coviello
Philip E Knapp
Jagadish Ulloor
Anqi Zhang
Brad Brooks
Ahn-Hoa Nguyen
Richard Eder
Nathan LeBrasseur
Ayan Elmi
Erica Appleman
Leife Hede-Brierley
Geeta Bhasin
Ashmeet Bhatia
Antonio Lazzari
Samuel Davis
Pengsheng Ni
Lauren Collins
Shalender Bhasin
Boston University · USBoston Medical Center · USVA Boston Healthcare System · USBrigham and Women's Hospital · US

Funding

TUFTS--FIELDINGP30AG031679 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · PI LEWIS LIPSITZ · 2008 to 2026
$23.9M
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR025771 · NCRR · BOSTON UNIVERSITY MEDICAL CAMPUS · PI CENTER, DAVID M. · 2008 to 2011
$17.6M
TESTOSTERONE SUPPLEMENTATION FOR MEN WITH SARCOPENIAU01AG014369 · NIA · BOSTON MEDICAL CENTER · PI BHASIN, SHALENDER · 2005 to 2011
$4.6M
NCRR NIH HHS 1UL1RR025771NIA NIH HHS 1U01AG14369NIA NIH HHS 5P30AG031679
6 · The paper itself

Abstract

contextTestosterone in Older Men with Mobility Limitations Trial determined the effects of testosterone on muscle performance and physical function in older men with mobility limitation. Trial's Data and Safety Monitoring Board recommended enrollment cessation due to increased frequency of adverse events in testosterone arm. The changes in muscle performance and physical function were evaluated in relation to participant's perception of change.

methodsMen aged 65 years and older, with mobility limitation, total testosterone 100-350 ng/dL, or free testosterone less than 50 pg/mL, were randomized to placebo or 10 g testosterone gel daily for 6 months. Primary outcome was leg-press strength. Secondary outcomes included chest-press strength, stair-climb, 40-m walk, muscle mass, physical activity, self-reported function, and fatigue. Proportions of participants exceeding minimally important difference in study arms were compared.

resultsOf 209 randomized participants, 165 had follow-up efficacy measures. Mean (SD) age was 74 (5.4) years and short physical performance battery score 7.7 (1.4). Testosterone arm exhibited greater improvements in leg-press strength, chest-press strength and power, and loaded stair-climb than placebo. Compared with placebo, significantly greater proportion of men receiving testosterone improved their leg-press and chest-press strengths (43% vs 18%, p = .01) and stair-climbing power (28% vs 10%, p = .03) more than minimally important difference. Increases in leg-press strength and stair-climbing power were associated with changes in testosterone levels and muscle mass. Physical activity, walking speed, self-reported function, and fatigue did not change.

conclusionsTestosterone administration in older men with mobility limitation was associated with patient-important improvements in muscle strength and stair-climbing power. Improvements in muscle strength and only some physical function measures should be weighed against the risk of adverse events in this population.

Indexed as

Mobility LimitationAgedDouble-Blind MethodExercise TestHumansMaleMotor ActivityMuscle, SkeletalMuscle StrengthPlacebosTestosteronePlacebosTestosterone

Identifiers

PMID21697501
PMCPMC3202898
OpenAlexW2124330890

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.